$0.6290
-0.0294-4.47%
Ult. Agg.: Oct 15, 9:26 AM
$0.6320
-0.0264-4.01%
Standard BioTools (LAB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Standard BioTools (LAB) ha pubblicato l'ultima guidance il maggio 5, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $80M - $85M per il periodo.
Rispetto alle previsioni precedenti, Standard BioTools ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Standard BioTools ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Standard BioTools. 21
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.02 | $-0.04 | $-0.04 |
| Actual | $-0.07 | $-0.04 | $0.05 | $-0.09 |
| Surprise | -133.3% | -100.0% | +225.0% | -125.0% |
| Revenue | ||||
| Estimate | $20.9M | $17.8M | $18.5M | $18.0M |
| Actual | $20.1M | $21.1M | $23.8M | $19.6M |
| Surprise | -3.90% | +19.1% | +28.6% | +8.62% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.02 | $-0.02 |
| Revenue | ||
| Consensus | $18.8M | $21.0M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.07 | $-0.03 | -133.3 % |
| Q1 | May 5, 2026 | $-0.04 | $-0.02 | -100.0 % |
| Q4 | Feb 24, 2026 | $0.05 | $-0.04 | 225.0 % |
| Q3 | Nov 4, 2025 | $-0.09 | $-0.04 | -125.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $20.10M | $20.92M | -3.90 % |
| Q1 | May 5, 2026 | $21.15M | $17.75M | 19.1 % |
| Q4 | Feb 24, 2026 | $23.80M | $18.50M | 28.6 % |
| Q3 | Nov 4, 2025 | $19.55M | $18.00M | 8.62 % |